Trial intelligence / Profile preview

Tropicetron in the treatment of schizophrenia

IRCT201106101556N24Phase 2Completed

Sponsor
Tehran University of Medical Sciences
Start
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of tropisetron in schizophrenia, sponsored by Tehran University of Medical Sciences. Started Jul 2011; status: completed.

02

Drugs

tropisetron
03

Conditions

schizophrenia

Beyond the preview

Go deeper on IRCT201106101556N24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201106101556N24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call